Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure

1996634 citationsJournal Article

Authors

Wilson S. Colucci

Milton Packer

Jonathan Sackner‐Bernstein

Sarah Young · GlaxoSmithKline (Netherlands)

Abstract

Carvedilol, when added to standard therapy, including an ACE inhibitor, reduces clinical progression in patients who are only mildly symptomatic with well-compensated heart failure.

Topics & Keywords

Heart Failure Treatment and Management Cardiac pacing and defibrillation studies Blood Pressure and Hypertension Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 94, Issue 11, pp. 2800-2806

DOI: 10.1161/01.cir.94.11.2800

Field-Weighted Citation Impact: 27.05